abnormal circulating cholesterol level, abnormal circulating lipid level, abnormal circulating pituitary hormone level, abnormal dendritic cell physiology, abnormal endoplasmic reticulum morphology, abnormal enterocyte morphology, abnormal glial cell physiology, abnormal hepatocyte morphology, abnormal innate immunity, abnormal interleukin level, abnormal intestinal epithelium morphology, abnormal large intestine crypts of Lieberkuhn morphology, abnormal leukocyte migration, abnormal locomotor activation, abnormal locomotor behavior, abnormal locomotor circadian rhythm, abnormal macrophage physiology, abnormal neuron differentiation, abnormal osteoclast physiology, abnormal pancreatic beta cell morphology, abnormal response to cardiac infarction, abnormal tumor necrosis factor level, abnormal white fat cell size, behavior/neurological phenotype, brain ischemia, cardiac interstitial fibrosis, colonic necrosis, decreased angiogenesis, decreased cerebral infarct size, decreased circulating alanine transaminase level, decreased circulating interleukin-1 beta level, decreased circulating tumor necrosis factor level, decreased fat cell size, decreased gonadal fat pad weight, decreased heart left ventricle weight, decreased heart weight, decreased interleukin-1 beta secretion, decreased interleukin-1 secretion, decreased interleukin-10 secretion, decreased interleukin-12 secretion, decreased interleukin-12b secretion, decreased interleukin-6 secretion, decreased liver tumor incidence, decreased lung tumor incidence, decreased lung weight, decreased macrophage cytokine production, decreased macrophage nitric oxide production, decreased microglial cell activation, decreased neuron apoptosis, decreased splenocyte proliferation, decreased susceptibility to Herpesvirales infection, decreased susceptibility to Herpesvirales infection induced morbidity/mortality, decreased susceptibility to bacterial infection induced morbidity/mortality, decreased susceptibility to hepatic steatosis, decreased susceptibility to kidney reperfusion injury, decreased susceptibility to parasitic infection, decreased thermal nociceptive threshold, decreased tumor necrosis factor secretion, growth/size/body region phenotype, homeostasis/metabolism phenotype, hyperresponsive to tactile stimuli, immune system phenotype, improved glucose tolerance, increased B cell apoptosis, increased adipocyte glucose uptake, increased colon adenoma incidence, increased energy expenditure, increased food intake, increased gastrointestinal tumor incidence, increased insulin secretion, increased insulin sensitivity, increased sensitivity to induced morbidity/mortality, increased susceptibility to bacterial infection induced morbidity/mortality, increased susceptibility to induced colitis, insulitis, muscle phenotype, nervous system phenotype, no abnormal phenotype detected, premature death, small pancreatic islets